TN

Tong Ren Tang Technologies Co LtdFRA Tong Ren Stock Report

Last reporting period 30 Jun, 2024

Updated 12 Nov, 2024

Last price

Market cap $B

0.798

Micro

Exchange

XFRA - Deutsche Boerse AG

TNG.F Stock Analysis

TN

Uncovered

Tong Ren Tang Technologies Co Ltd is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

35/100

Low score

Market cap $B

0.798

Dividend yield

6.96 %

Shares outstanding

1 280.78 B

Tong Ren Tang Technologies Co., Ltd. engages in the production and distribution of Chinese medicine. The company is headquartered in Beijing, Beijing and currently employs 4,017 full-time employees. The company went IPO on 2000-10-31. The firm's main businesses includes the production, retail and wholesale of traditional Chinese medicine products and health care products and the provision of traditional Chinese medicine diagnosis and treatment services. The firm is also engaged in the production, processing and acquisition of Chinese herbal medicines, drug sales, medical services and advertising. The firm mainly distributes its products in the domestic market and overseas markets.

View Section: Eyestock Rating